Search

You searched for "ophthalmoscope"

2953 results found

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...

The Eyes Have It and World Eye Health Day - A Q&A with Marsha de Cordova

15 December 2023 | TEHI, WEHD, Politics, eye health, report, change, sight loss
Westminster Eye Health Day is the flagship parliamentary event of The Eyes have It, a partnership of Roche, Macular Society, Fight for Sight, The Royal College of Ophthalmologists, Association of Optometrists and RNIB and has returned for its third year, sponsored by Marsha de Cordova MP.

International Women’s Day 2025: In Conversation With Dr Michelle Le Cheminant

9 March 2025 | international womans day, conversation, Q&A, ophthalmology, gender
Women make up 70% of the global health and social workforce but hold only 25% of leadership roles. In ophthalmology, women represent just 25-30% of ophthalmologists. Research shows that hospitals with increased female surgeons and anesthetists have lower odds of...

Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin

3 June 2024 | | EYE - Vitreo-Retinal
Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...

Simulation in ophthalmology: a pedagogic viewpoint

1 April 2017 | | EYE - Cataract, EYE - Refractive
The advent of simulation technology has enhanced modern medical training. The first utilisation of simulation was in 1929 where Edward Link used this concept to develop a mechanical flight simulator [1]. Industries such as aviation, nuclear power and the military...

A tale of two membranes

1 February 2016 | | EYE - Vitreo-Retinal
It was the best of times, it was the worst of times... It was the season of Light, it was the season of Darkness... I am fortunate to work on a vitreoretinal firm at the moment and only a few...

Pharmacopoeia of the Royal Infirmary of Edinburgh

4 February 2021 | | EYE - General
The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....

DMEK vs. UT-DSAEK: has the debate been finally concluded?

1 October 2021 | | EYE - Cornea, EYE - General
In recent years the surgical treatment of corneal endothelial dystrophy has progressed tremendously. Descemet’s membrane endothelial keratoplasty (DMEK) is the newest iteration in the line of rapid surgical advances that has taken place. However, the previously accepted gold standard prior...

Four pillars: The importance of clinical research

2 October 2025 | | EYE - General
This series explores the four pillars of advanced clinical practice and here, Rebecca Turner explores the pillar of clinical research. The role of the ophthalmic advanced nurse practitioner, as with all registered practitioners allied to ophthalmology, is on an upward...

Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa

1 June 2022 | | EYE - Cornea, EYE - General
Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...

The David J Apple International Laboratory for Ocular Pathology – a legacy of pioneering IOL research

1 October 2016 | | EYE - Cataract, EYE - Refractive
David Apple and Gerd Auffarth. The Apple Lab at the David J Apple Center for Vision Research in Heidelberg is a thriving international laboratory for research into intraocular devices. The lab continues the work of David J Apple, a world-renowned...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...